- Home
- DIAX vs FLGT Comparison
DIAX vs FLGT Comparison
Compare DIAX & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIAX
- FLGT
- Stock Information
- Founded
- DIAX 2005
- FLGT 2011
- Country
- DIAX United States
- FLGT United States
- Employees
- DIAX N/A
- FLGT N/A
- Industry
- DIAX Finance Companies
- FLGT Medical Specialities
- Sector
- DIAX Finance
- FLGT Health Care
- Exchange
- DIAX Nasdaq
- FLGT Nasdaq
- Market Cap
- DIAX 552.4M
- FLGT 508.7M
- IPO Year
- DIAX N/A
- FLGT 2016
- Fundamental
- Price
- DIAX $15.25
- FLGT $16.46
- Analyst Decision
- DIAX
- FLGT Hold
- Analyst Count
- DIAX 0
- FLGT 1
- Target Price
- DIAX N/A
- FLGT $22.00
- AVG Volume (30 Days)
- DIAX 96.6K
- FLGT 225.7K
- Earning Date
- DIAX 01-01-0001
- FLGT 02-28-2025
- Dividend Yield
- DIAX 7.93%
- FLGT N/A
- EPS Growth
- DIAX N/A
- FLGT N/A
- EPS
- DIAX N/A
- FLGT N/A
- Revenue
- DIAX N/A
- FLGT $277,761,000.00
- Revenue This Year
- DIAX N/A
- FLGT N/A
- Revenue Next Year
- DIAX N/A
- FLGT $16.00
- P/E Ratio
- DIAX N/A
- FLGT N/A
- Revenue Growth
- DIAX N/A
- FLGT N/A
- 52 Week Low
- DIAX $12.80
- FLGT $15.99
- 52 Week High
- DIAX $15.12
- FLGT $25.50
- Technical
- Relative Strength Index (RSI)
- DIAX 39.73
- FLGT 42.71
- Support Level
- DIAX $15.34
- FLGT $16.47
- Resistance Level
- DIAX $15.55
- FLGT $17.39
- Average True Range (ATR)
- DIAX 0.16
- FLGT 0.54
- MACD
- DIAX -0.04
- FLGT 0.10
- Stochastic Oscillator
- DIAX 5.77
- FLGT 33.57
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.